BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12649172)

  • 21. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: no correlation with subclinical lymph node invasion and disease recurrence.
    Fortin A; Guerry M; Guerry R; Talbot M; Parise O; Schwaab G; Bosq J; Bourhis J; Salvatori P; Janot F; Busson P
    Clin Cancer Res; 1997 Sep; 3(9):1609-14. PubMed ID: 9815850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
    Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenes in head and neck cancer.
    Irish JC; Bernstein A
    Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
    Bubendorf L; Kononen J; Koivisto P; Schraml P; Moch H; Gasser TC; Willi N; Mihatsch MJ; Sauter G; Kallioniemi OP
    Cancer Res; 1999 Feb; 59(4):803-6. PubMed ID: 10029066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma.
    Davidson BJ; Lydiatt WM; Abate MP; Schantz SP; Chaganti RS
    Head Neck; 1996; 18(6):512-21. PubMed ID: 8902564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma.
    Ishiguro R; Fujii M; Yamashita T; Tashiro M; Tomita T; Ogawa K; Kameyama K
    Anticancer Res; 2003; 23(6D):5213-20. PubMed ID: 14981992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of genetic alterations in different sites of head and neck cancer.
    Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA
    Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin.
    Patmore HS; Ashman JN; Stafford ND; Berrieman HK; MacDonald A; Greenman J; Cawkwell L
    Cancer Lett; 2007 Dec; 258(1):55-62. PubMed ID: 17920192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.
    Bei R; Budillon A; Masuelli L; Cereda V; Vitolo D; Di Gennaro E; Ripavecchia V; Palumbo C; Ionna F; Losito S; Modesti A; Kraus MH; Muraro R
    J Pathol; 2004 Nov; 204(3):317-25. PubMed ID: 15476268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers.
    Lin SC; Liu CJ; Ko SY; Chang HC; Liu TY; Chang KW
    J Pathol; 2005 Aug; 206(4):417-22. PubMed ID: 15906274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck.
    Niméus E; Baldetorp B; Bendahl PO; Rennstam K; Wennerberg J; Akervall J; Fernö M
    Oral Oncol; 2004 Jul; 40(6):624-9. PubMed ID: 15063391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
    Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
    Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
    Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
    Mrhalova M; Kodet R
    Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas.
    Nguyen DC; Parsa B; Close A; Magnusson B; Crowe DL; Sinha UK
    Int J Oncol; 2003 Jun; 22(6):1285-90. PubMed ID: 12738995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
    Henriksson E; Baldetorp B; Borg A; Kjellen E; Akervall J; Wennerberg J; Wahlberg P
    Acta Oncol; 2006; 45(3):300-5. PubMed ID: 16644573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).
    Freier K; Schwaenen C; Sticht C; Flechtenmacher C; Mühling J; Hofele C; Radlwimmer B; Lichter P; Joos S
    Oral Oncol; 2007 Jan; 43(1):60-6. PubMed ID: 16807070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic relevance of gene amplifications and coamplifications in breast cancer.
    Al-Kuraya K; Schraml P; Torhorst J; Tapia C; Zaharieva B; Novotny H; Spichtin H; Maurer R; Mirlacher M; Köchli O; Zuber M; Dieterich H; Mross F; Wilber K; Simon R; Sauter G
    Cancer Res; 2004 Dec; 64(23):8534-40. PubMed ID: 15574759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.